Abstract
Both the nitrite and prostaglandin E2 (PGE2) release caused by lipopolysaccharide (LPS) in J774 macrophages are inhibited by SB 203580, a specific p38 mitogen-activated protein kinase (MAPK) inhibitor, in a concentration-dependent manner. The 50% inhibitory concentration (IC50) for nitrite and PGE2 responses was 1 microm and 0.5 microm, respectively. Inhibition was marked following simultaneous treatment with SB 203580 and LPS, and was much reduced when SB 203580 was added 6 hr after LPS treatment. In parallel, LPS induction of inducible NO synthase (iNOS) and cyclo-oxygenase-2 (COX-2) proteins and their steady-state levels of mRNA were reduced by SB 203580. LPS activation of nuclear factor-kappa B (NF-kappaB), activator protein-1 (AP-1) and p38 MAPK was also inhibited by SB 203580. These results suggest a crucial role of p38 MAPK in regulation of the transcriptional level of endotoxin LPS-induced iNOS and COX-2 protein expression.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
-
Calcium-Calmodulin-Dependent Protein Kinases / physiology*
-
Cell Culture Techniques
-
Cell Line
-
Cyclooxygenase 2
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Imidazoles / pharmacology
-
Isoenzymes / metabolism*
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology*
-
Macrophages / enzymology*
-
Mice
-
Mitogen-Activated Protein Kinases*
-
Nitric Oxide Synthase / metabolism*
-
Prostaglandin-Endoperoxide Synthases / metabolism*
-
Pyridines / pharmacology
-
Transcription, Genetic / drug effects
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Enzyme Inhibitors
-
Imidazoles
-
Isoenzymes
-
Lipopolysaccharides
-
Pyridines
-
Nitric Oxide Synthase
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Calcium-Calmodulin-Dependent Protein Kinases
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
SB 203580